Processing

Please wait...

Settings

Settings

Goto Application

1. WO2004006940 - MEDICINAL COMPOSITION FOR DRUG-INDUCED NEUROPATHY

Publication Number WO/2004/006940
Publication Date 22.01.2004
International Application No. PCT/JP2003/008708
International Filing Date 09.07.2003
Chapter 2 Demand Filed 17.11.2003
IPC
A61K 31/7068 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706containing six-membered rings with nitrogen as a ring hetero atom
7064containing condensed or non-condensed pyrimidines
7068having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
C07H 19/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
19Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
02sharing nitrogen
04Heterocyclic radicals containing only nitrogen as ring hetero atom
06Pyrimidine radicals
10with the saccharide radical being esterified by phosphoric or polyphosphoric acids
CPC
A61K 31/7068
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7052having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
706containing six-membered rings with nitrogen as a ring hetero atom
7064containing condensed or non-condensed pyrimidines
7068having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
C07H 19/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
19Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides ; Anhydro-derivatives thereof
02sharing nitrogen
04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
06Pyrimidine radicals
10with the saccharide radical esterified by phosphoric or polyphosphoric acids
Applicants
  • YAMASA CORPORATION [JP]/[JP] (AllExceptUS)
  • ENDO, Kazuki [JP]/[JP] (UsOnly)
  • KAMEI, Junzo [JP]/[JP] (UsOnly)
Inventors
  • ENDO, Kazuki
  • KAMEI, Junzo
Agents
  • TAKASHIMA, Hajime
Priority Data
2002-20271511.07.2002JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) MEDICINAL COMPOSITION FOR DRUG-INDUCED NEUROPATHY
(FR) COMPOSITION MEDICAMENTEUSE CONTRE LA NEUROPATHIE MEDICAMENTEUSE
(JA) 薬剤誘発性神経障害用医薬組成物
Abstract
(EN)
A preventive/remedy for drug-induced neuropathy which contains cytidine 5’-diphosphate choline (CDP-choline) as the active ingredient. This preventive/remedy for drug-induced neuropathy has a potent effect of improving drug-induced neuropathy and a high safety.
(FR)
L'invention concerne un agent prophylactique/thérapeutique contre la neuropathie médicamenteuse, contenant de la cytidine-5'-diphospho-choline (CDP-choline) comme principe actif. Cet agent prophylactique/thérapeutique contre la neuropathie médicamenteuse est efficace dans l'amélioration de la neuropathie médicamenteuse et présente une grande innocuité.
(JA)
本発明は、シチジン5'−二リン酸コリン(CDP−コリン)を有効成分として含有してなる薬剤誘発性神経障害の予防・治療剤に関する。本発明の薬剤誘発性神経障害の予防・治療剤は、薬剤誘発性神経障害に対し強力な改善効果を有し、安全性にも優れている。
Latest bibliographic data on file with the International Bureau